STAT Plus: AstraZeneca strikes a ‘novel’ deal with a Medicare plan to lower patient out-of-pocket costs
“The novel aspect is that they are creating incentives for patients for these value-based contracts," says Stacie Dusetzina of Vanderbilt University.
No hay comentarios:
Publicar un comentario